iiinova — where your digital self keeps evolving

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 19h

📄New from the #Transfusion Evidence Alert: Early red blood cell transfusion strategy in septic shock among patients with cancer: the TRANSPORT randomized controlled trial by Pène et al. 🔗Transfusion Evidence Library link in replies #MedSky

Image showing a PICO summary for:
Early red blood cell transfusion strategy in septic shock among patients with cancer: the TRANSPORT randomized controlled trial by Pène et al.
Featured in the Transfusion Evidence Alert – September 2026

132

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 19h

📄From the #Transfusion Evidence Alert: Intravenous iron to treat anaemia before cardiac surgery (ITACS): international, double blind, placebo controlled randomised trial by Myles et al. 🔗Transfusion Evidence Library link in replies #MedSky

Image showing a PICO summary for:
Intravenous iron to treat anaemia before cardiac surgery (ITACS): international, double blind, placebo controlled randomised trial by Myles et al.
Featured in the Transfusion Evidence Alert – September 2026

132

Stem Cell Evidence @stemcellevidence.bsky.social · 21h

🟣 New from the #StemCellEvidence alert: 📑 GRIMM-II: A two-stage real-time algorithm for nine-locus HLA imputation and matching with up to three mismatches by Kirshenboim et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
GRIMM-II: A two-stage real-time algorithm for nine-locus HLA imputation and matching with up to three mismatches by Kirshenboim et al.
featured in the Stem Cell Evidence Alert - September 2026

132

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 29/09/2026

📄From the #Transfusion Evidence Alert: Impact of tranexamic acid on outcomes in early-admitted patients with aneurysmal subarachnoid hemorrhage: a systematic review and bayesian meta-analysis of randomized controlled trials by Łajczak et al. 🔗Transfusion Evidence Library link in replies #MedSky

Image showing a PICO summary for:
Impact of tranexamic acid on outcomes in early-admitted patients with aneurysmal subarachnoid hemorrhage: a systematic review and bayesian meta-analysis of randomized controlled trials by Łajczak et al.
Featured in the Transfusion Evidence Alert – September 2026

132

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 29/09/2026

📄New from the #Transfusion Evidence Alert: All-Trans Retinoic Acid plus Eltrombopag for Refractory/Relapsed Immune Thrombocytopenia by Fu et al. 🔗Transfusion Evidence Library link in replies #MedSky

$Image showing a PICO summary for: All-Trans Retinoic Acid plus Eltrombopag for Refractory/Relapsed Immune Thrombocytopenia by Fu et al. Featured in the Transfusion Evidence Alert – September 2026$

133

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 28/09/2026

➡️New from the #TransfusionEvidence Alert: 📑Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial by Höchsmann et al. 🔗Link in the comments. #MedSky

Image showing a PICO summary for: Eltrombopag plus cyclosporine A for moderate aplastic anemia (EMAA): a placebo-controlled, double-blind, phase 3 trial
by Höchsmann et al.
featured in the Transfusion Evidence Alert - September 2026

121

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 28/09/2026

🆕 From the #TransfusionEvidence Alert: 📑 Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia by Han et al. 🔗Link in the comments.

Image showing a PICO summary for:
Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia
by Han et al.
featured in the Transfusion Evidence Alert - September 2026

131

Stem Cell Evidence @stemcellevidence.bsky.social · 29/09/2026

🟣 The #StemCellEvidence alert - September 2026, is out! 🔗 See the link in the comments for the top 10 articles #MedSky

Image showing an extract of the Stem Cell Evidence Alert - September 2026

121

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 25/09/2026

📄From the #Transfusion Evidence Alert: Perioperative albumin versus other fluids to prevent cardiac surgery-associated kidney injury: a systematic review and meta-analysis of randomized trials by Darlison et al. 🔗Transfusion Evidence Library link in replies #MedSky

Image showing a PICO summary for:
Perioperative albumin versus other fluids to prevent cardiac surgery-associated kidney injury: a systematic review and meta-analysis of randomized trials by Darlison et al.
Featured in the Transfusion Evidence Alert – September 2026

132

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 25/09/2026

📄New from the #Transfusion Evidence Alert: AI and Blood Banking: Predicting Transfusion Demand – A Systematic Review of Forecasting Approaches by Engelke et al. 🔗 Transfusion Evidence Library link in replies #MedSky

Image showing a PICO summary for:
AI and Blood Banking: Predicting Transfusion Demand – A Systematic Review of Forecasting Approaches by Engelke et al.
Featured in the Transfusion Evidence Alert – September 2026

144

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 24/09/2026

📄From the #Transfusion Evidence Alert: Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy By Bus et al. 🔗Transfusion Evidence Library link in replies #MedSky

Image showing a PICO summary for:
Subcutaneous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy by Bus et al.
Featured in the Transfusion Evidence Alert – September 2026

132

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 24/09/2026

📆Article of the month from the #Transfusion Evidence Alert: Cold and Room-Temperature Platelets in Cardiac Surgery: The CHIPS Randomized Clinical Trial By Spinella et al. 🔗Transfusion Evidence Library link in replies #MedSky

Image showing a PICO summary for:
Cold and Room-Temperature Platelets in Cardiac Surgery: The CHIPS Randomized Clinical Trial by Spinella et al.
Featured in the Transfusion Evidence Alert – September 2026

132

Reposted by Stem Cell Evidence

Systematic Review Initiative @sritransfusion.bsky.social · 24/09/2026

📆Today is #WorldCancerResearchDay. #StemCellTransplant is a valuable treatment option for some types of cancer, and our Stem Cell Evidence Library stores many articles on this topic. 🔗Link to the Stem Cell Evidence Library in replies

122

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 23/09/2026

🆕 The #Transfusion Evidence Alert - September 2026 is out! 🩸See the latest top articles in #TransfusionMedicine ✅Each top article has a quick-format PICO summary 🔗Link in the comments #MedSky

Image showing an extract of the Transfusion Evidence Alert

132

Reposted by Stem Cell Evidence

Systematic Review Initiative @sritransfusion.bsky.social · 17/09/2026

🟠Today we are celebrating #WorldPatientSafetyDay and also five years of the Transfusion Evidence Round-Up, which we produce in partnership with @isbt.bsky.social. 🔗Read more on the SRI website (link in replies)

Picture of the ISBT-SRI Transfusion Evidence Round-Up Team

143

Stem Cell Evidence @stemcellevidence.bsky.social · 03/09/2026

🟣 New from the #StemCellEvidence alert: 📑 CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results by Silbert et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results
by Silbert et al.
Link in the comments
featured in the Stem Cell Evidence Alert - July/August 2026

132

Stem Cell Evidence @stemcellevidence.bsky.social · 03/09/2026

🆕 From the #StemCellEvidence alert: 📑 CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trial by Tang et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trial
by Tang et al.
featured in the Stem Cell Evidence Alert - July/August 2026

132

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 02/09/2026

📄New from the #Transfusion Evidence Alert: Diagnostic accuracy of reticulocyte haemoglobin content in detecting iron deficiency without anaemia in blood donors: A systematic review and meta-analysis By Yanyiam et al. 🔗Transfusion Evidence Library link in replies #MedSky

Image showing a PICO summary for:
Diagnostic accuracy of reticulocyte haemoglobin content in detecting iron deficiency without anaemia in blood donors: A systematic review and meta-analysis by Yanyiam et al.
Featured in the Transfusion Evidence Alert – August 2026

122

Stem Cell Evidence @stemcellevidence.bsky.social · 02/09/2026

100

Stem Cell Evidence @stemcellevidence.bsky.social · 02/09/2026

110

Reposted by Stem Cell Evidence

Systematic Review Initiative @sritransfusion.bsky.social · 01/09/2026

📆September is #BloodCancerAwarenessMonth. To honour this, episode 4 of our Talking Transfusion Podcast explores recent relevant findings, clinical challenges, and how transfusion supports those living with leukemia, lymphoma, myeloma, and related conditions. Links to the podcast here: bit.ly/45VghOf

bit.ly

Talking Transfusion Podcast

A collaborative podcast featuring the latest systematic reviews and trials

033

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 01/09/2026

📄New from the #Transfusion Evidence Alert: Effect of Blood Donation in the Glycemic Control of Prediabetic Donors: A Blinded Randomized Controlled Trial By Mora-Gonzalez et al. 🔗Transfusion Evidence Library link in replies #MedSky

Image showing a PICO summary for:
Effect of Blood Donation in the Glycemic Control of Prediabetic Donors: A Blinded Randomized Controlled Trial by Mora-Gonzalez et al.
Featured in the Transfusion Evidence Alert – August 2026

122

Stem Cell Evidence @stemcellevidence.bsky.social · 01/09/2026

🟣 New from the #StemCellEvidence alert: 📑 Randomized Trial of Two Fractionation Schedules of Myeloablative Busulfan with Fludarabine and Cladribine in Acute Myeloid Leukemia or Myelodysplastic Syndromes by Popat et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
Randomized Trial of Two Fractionation Schedules of Myeloablative Busulfan with Fludarabine and Cladribine in Acute Myeloid Leukemia or Myelodysplastic Syndromes
by Popat et al.
featured in the Stem Cell Evidence Alert - July/August 2026

132

Stem Cell Evidence @stemcellevidence.bsky.social · 01/09/2026

🆕From the #StemCellEvidence alert: 📑Reduced-Dose Post-Transplant Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis in Matched Donor Allogeneic Stem Cell Transplantation: A #SystematicReview of Efficacy and Toxicity by Shafqat et al. 🔗Link in the comments #MedSky

Image showing a PICO summary for:
Reduced-Dose Post-Transplant Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis in Matched Donor Allogeneic Stem Cell Transplantation: A Systematic Review of Efficacy and Toxicity
by Shafqat et al.
featured in the Stem Cell Evidence Alert - July/August 2026

121

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 28/08/2026

📄New from the #Transfusion Evidence Alert: Mortality effect of albumin fluid resuscitation in adults with septic shock: a systematic review and dual frequentist-Bayesian meta-analysis of randomised trials By Mendes et al. 🔗Transfusion Evidence Library link in replies #MedSky

Image showing a PICO summary for:
Mortality effect of albumin fluid resuscitation in adults with septic shock: a systematic review and dual frequentist-Bayesian meta-analysis of randomised trials by Mendes et al.
Featured in the Transfusion Evidence Alert – August 2026

132

Stem Cell Evidence @stemcellevidence.bsky.social · 28/08/2026

🟣 New from the #StemCellEvidence alert: 📑 Incidence, molecular and clinical characteristics of donor-derived hematologic malignancies after allogeneic stem cell transplantation for myeloid malignancies by Perekhrestenko et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
Incidence, molecular and clinical characteristics of donor-derived hematologic malignancies after allogeneic stem cell transplantation for myeloid malignancies
by Perekhrestenko et al.

featured in the Stem Cell Evidence Alert - July/August 2026

121

Stem Cell Evidence @stemcellevidence.bsky.social · 28/08/2026

🆕 From the #StemCellEvidence alert: 📑 Chronic GVHD Consortium CATCH Study: Incidence, initial presentation and risk factors for chronic GVHD development by Pidala et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:

featured in the Stem Cell Evidence Alert - July/August 2026

121

Stem Cell Evidence @stemcellevidence.bsky.social · 27/08/2026

🟣 New from the #StemCellEvidence alert: 📑 Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation by Nishiwaki et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation
by Nishiwaki et al.
featured in the Stem Cell Evidence Alert - July/August 2026

122

Stem Cell Evidence @stemcellevidence.bsky.social · 27/08/2026

🆕 From the #StemCellEvidence alert: 📑 Evaluation of ex-utero collection for umbilical cord blood banking: A randomized clinical trial comparing cord blood quality with the in-utero technique by Ozbey et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
Evaluation of ex-utero collection for umbilical cord blood banking: A randomized clinical trial comparing cord blood quality with the in-utero technique
by Ozbey et al.
featured in the Stem Cell Evidence Alert - July/August 2026

122

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 27/08/2026

📄From the #Transfusion Evidence Alert: HLA selected red cell transfusions to prevent HLA sensitisation: a prospective, double-blinded, randomised controlled trial by McComish et al. 🔗Transfusion Evidence Library link in replies #MedSky

Image showing a PICO summary for:
HLA selected red cell transfusions to prevent HLA sensitisation: a prospective, double-blinded, randomised controlled trial by McComish et al.
Featured in the Transfusion Evidence Alert – August 2026

122

Stem Cell Evidence @stemcellevidence.bsky.social · 26/08/2026

🟣 New from the #StemCellEvidence alert: 📑 Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial by Ladetto et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial
by Ladetto et al.
featured in the Stem Cell Evidence Alert - July/August 2026

100

Stem Cell Evidence @stemcellevidence.bsky.social · 26/08/2026

🆕 From the #StemCellEvidence alert: 📑 Comparison of Allo-HSCT outcomes after CAR-T therapy versus chemotherapy in pediatric patients with relapsed/refractory B-ALL: a retrospective study by Li et al. 🔗 Link in the comments #MedSky

$Image showing a PICO summary for: Comparison of Allo-HSCT outcomes after CAR-T therapy versus chemotherapy in pediatric patients with relapsed/refractory B-ALL: a retrospective study by Li et al. featured in the Stem Cell Evidence Alert - July/August 2026$

100

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 26/08/2026

📄New from the #Transfusion Evidence Alert: Efficacy and safety of different doses of intravenous immunoglobulin combined with phototherapy in neonatal hemolytic disease: a systematic review and meta-analysis By Huang et al. 🔗Transfusion Evidence Library link in replies #MedSky

Image showing a PICO summary for:
Efficacy and safety of different doses of intravenous immunoglobulin combined with phototherapy in neonatal hemolytic disease: a systematic review and meta-analysis by Huang et al.
Featured in the Transfusion Evidence Alert – August 2026

122

Stem Cell Evidence @stemcellevidence.bsky.social · 25/08/2026

📄New from the #StemCellEvidence alert: Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee by Gurnari et al. 🔗Link in the replies #MedSky

Image showing PICO summary for:
Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee by Gurnari et al.
Featured in the Stem Cell Evidence Alert - August 2026

133

Stem Cell Evidence @stemcellevidence.bsky.social · 25/08/2026

📄From the #StemCellEvidence alert: High-dose chemotherapy followed by autologous stem-cell transplantation versus non-myeloablative consolidation in primary CNS lymphoma (MATRix/IELSG43): a randomised phase 3 trial by Illerhaus et al. 🔗Link in the replies #MedSky

Image showing PICO summary for:
High-dose chemotherapy followed by autologous stem-cell transplantation versus non-myeloablative consolidation in primary CNS lymphoma (MATRix/IELSG43): a randomised phase 3 trial by Illerhaus et al.
Featured in the Stem Cell Evidence Alert - August 2026

122

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 25/08/2026

📄From the #Transfusion Evidence Alert: Optimal Route of Tranexamic Acid Administration in Total Knee Arthroplasty: A Bayesian Network Meta-Analysis with Decision-Analytic Cost Evaluation by Hershfeld et al. 🔗Transfusion Evidence Library link in replies #MedSky

Image showing a PICO summary for:
Optimal Route of Tranexamic Acid Administration in Total Knee Arthroplasty: A Bayesian Network Meta-Analysis with Decision-Analytic Cost Evaluation by Hershfeld et al.
Featured in the Transfusion Evidence Alert – August 2026

122

Stem Cell Evidence @stemcellevidence.bsky.social · 24/08/2026

📄 From the #StemCellEvidence alert: The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy by Greco et al. 🔗 Link in the replies #MedSky

Image showing a PICO summary for:
The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy by Greco et al.
Featured in the Stem Cell Evidence Alert - August 2026

100

Stem Cell Evidence @stemcellevidence.bsky.social · 24/08/2026

📄 New from the #StemCellEvidence alert: Pretransplant Blinatumomab Is Associated With Reduced Relapse and Improved Disease-Free Survival in Adults With B-Cell ALL Undergoing Allogeneic Hematopoietic Cell Transplantation by Ginosyan et al. 🔗 Link in the replies #MedSky

Image showing a PICO summary for:
Pretransplant Blinatumomab Is Associated With Reduced Relapse and Improved Disease-Free Survival in Adults With B-Cell ALL Undergoing Allogeneic Hematopoietic Cell Transplantation by Ginosyan et al.
Featured in the Stem Cell Evidence Alert - August 2026

100

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 21/08/2026

📄From the #Transfusion Evidence Alert: Barriers and enablers to non-remunerated plasma donation: A meta-synthesis of the qualitative literature using the theoretical domains framework by Etherington et al. 🔗Transfusion Evidence Library link in replies #MedSky

Image showing a PICO summary for:
Barriers and enablers to non-remunerated plasma donation: A meta-synthesis of the qualitative literature using the theoretical domains framework by Etherington et al.
Featured in the Transfusion Evidence Alert – August 2026

122

Stem Cell Evidence @stemcellevidence.bsky.social · 21/08/2026

🟣 New from the #StemCellEvidence alert: 📑 Cellular therapy in mantle cell lymphoma: recommendations from the EBMT practice harmonisation and guidelines committee by Dreger et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
Cellular therapy in mantle cell lymphoma: recommendations from the EBMT practice harmonisation and guidelines committee
by Dreger et al.
featured in the Stem Cell Evidence Alert - July/August 2026

100

Stem Cell Evidence @stemcellevidence.bsky.social · 21/08/2026

🆕 From the #StemCellEvidence alert: 📑 Significance of CD34+ Cell Dose on Outcomes of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation in AML: An Analysis Stratified by MRD Status by Gang et al. 🔗Link in the comments #MedSky

Image showing a PICO summary for:
Significance of CD34+ Cell Dose on Outcomes of Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation in AML: An Analysis Stratified by MRD Status
by Gang et al.
featured in the Stem Cell Evidence Alert - July/August 2026

111

Stem Cell Evidence @stemcellevidence.bsky.social · 20/08/2026

🟣 New from the #StemCellEvidence alert: 📑 Donor-specific transplant outcomes from BMT CTN 1702: a multicenter prospective biologic assignment trial by Bashey et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
Donor-specific transplant outcomes from BMT CTN 1702: a multicenter prospective biologic assignment trial
by Bashey et al.

featured in the Stem Cell Evidence Alert - July/August 2026

100

Stem Cell Evidence @stemcellevidence.bsky.social · 20/08/2026

🆕 From the #StemCellEvidence alert: 📑 Better 10-Year Cerebrovascular Outcome After Transplant Than on Standard-Care in Sickle Cell Anemia: DREPAGREFFE Trial by Bernaudin et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
Better 10-Year Cerebrovascular Outcome After Transplant Than on Standard-Care in Sickle Cell Anemia: DREPAGREFFE Trial
by Bernaudin et al.
featured in the Stem Cell Evidence Alert - July/August 2026

100

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 20/08/2026

📄New from the #Transfusion Evidence Alert: Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial By Al-Samkari et al. 🔗Transfusion Evidence Library link in replies

Image showing a PICO summary for:
Avatrombopag Versus Placebo for Persistent Chemotherapy-Induced Thrombocytopenia in GI Cancers: The Phase II ACT-GI Trial by Al-Samkari et al.
Featured in the Transfusion Evidence Alert – August 2026

122

Reposted by Stem Cell Evidence

Transfusion Evidence Library @transfusionlib.bsky.social · 19/08/2026

🆕 The #Transfusion Evidence Alert - August 2026 is out! 🩸See the top articles in #TransfusionMedicine ✅Each top article has a quick-format PICO summary, so you can rapidly identify what you need to read 🔗Link in the comments #MedSky

Image showing an extract of the Transfusion Evidence Alert - August 2026

112

Stem Cell Evidence @stemcellevidence.bsky.social · 19/08/2026

✅ New from the #StemCellEvidence alert: 📑 Impact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission (...) by Maffini et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for:
Impact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation
by Maffini et al.
featured in the Stem Cell Evidence Alert - July/August 2026

132

Stem Cell Evidence @stemcellevidence.bsky.social · 19/08/2026

🟣 From the #StemCellEvidence alert: 🆕 Infection Burden in Mismatched Unrelated Donor #HematopoieticCellTransplantation: Results from the ACCESS Trial by Auletta et al. 🔗 Link in the comments #MedSky

Image showing a PICO summary for the article:
Infection Burden in Mismatched Unrelated Donor #HematopoieticCellTransplantation: Results from the ACCESS Trial
by Auletta et al.
featured in the Stem Cell Evidence Alert - July/August 2026

122

Stem Cell Evidence @stemcellevidence.bsky.social · 18/08/2026

🆕 The #StemCellEvidence alert for July/August is out! 🟣 See link in the comments.

Image showing an extract of the Stem Cell Evidence Alert - July/August 2026

132